本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BriaCell Therapeutics Corp.

4.59
-0.4100-8.20%
盤前4.590.00000.00%09:13 EDT
成交量:71.23萬
成交額:334.51萬
市值:3,110.23萬
市盈率:-0.66
高:5.01
開:5.01
低:4.53
收:5.00
資料載入中...
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/22

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/04/22

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/03/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/12

重要事件披露

Form 8-K - Current report
2025/02/13

重要事件披露

Form 8-K - Current report
2025/02/06

重要事件披露

Form 8-K - Current report
2025/02/05

重要事件披露

Form 8-K - Current report
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/03

重要事件披露

Form 8-K - Current report
2025/01/03

重要事件披露

Form 8-K - Current report
2024/12/16

重要事件披露

Form 8-K - Current report
2024/12/16

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/12/13

重要事件披露

Form 8-K - Current report
2024/12/12

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/10

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/05

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/25

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]